Neuralink’s device has enabled its first patient to play video games, surf the web, update social media, and control a laptop cursor. Reuters
Elon Musk announced that Neuralink has successfully implanted its brain chip in a second patient, marking a significant step forward for the startup. The device, designed to help paralyzed individuals control digital devices using only their thoughts, has shown promising results.
Musk revealed that the second patient, like the first, suffers from a spinal cord injury. This new implant has 400 of its 1,024 electrodes active and functioning. According to Musk, the procedure "seems to have gone extremely well" and is showing a strong performance. He did not share the exact date of the surgery but indicated that Neuralink aims to provide implants to eight more patients this year as part of its ongoing trials.
The first patient, Noland Arbaugh, who has been using the implant since January, shared his experiences on a podcast. Arbaugh, who was previously reliant on a stick to tap a tablet screen, can now control his computer simply by thinking. The implant has greatly increased his independence and reduced his dependence on caregivers. Despite initial problems where the implant’s tiny wires retracted and decreased the number of functioning electrodes, Neuralink has managed to restore the device’s effectiveness. Arbaugh has even surpassed his previous record for cursor control speed, achieving this with only a fraction of the electrodes operational.
During the same podcast, Musk discussed his conversations with Donald Trump about creating a commission to enhance government efficiency by easing business regulations. Musk criticized current regulations for stifling innovation and expressed his willingness to participate in efforts to streamline the regulatory environment.
The development of Neuralink’s device is a major breakthrough for individuals with severe disabilities, offering them new possibilities for communication and interaction with digital technology. As Neuralink moves forward, it aims to further refine its technology and expand its impact, potentially transforming the lives of many more patients.
